M. Di Martile

发表

Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages

V. Farini, A. Sica, E. Gallo, 2020, Journal for ImmunoTherapy of Cancer.

Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma

D. Del Bufalo, R. Ragno, S. Garzoli, 2020, Cancers.

Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells

S. Carradori, D. Trisciuoglio, A. Mai, 2016, Oncotarget.

Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb

D. Trisciuoglio, B. Calabretta, M. Rizzo, 2018, Journal of Experimental & Clinical Cancer Research.

BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.

M. Biffoni, D. Trisciuoglio, M. Rizzo, 2013, Carcinogenesis.

A double point mutation at residues Ile14 and Val15 of Bcl‐2 uncovers a role for the BH4 domain in both protein stability and function

S. Karamanou, J. Parys, H. de Smedt, 2018, The FEBS journal.

Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells

V. Farini, S. Carradori, D. Trisciuoglio, 2020, Journal of experimental & clinical cancer research : CR.

Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules

D. Trisciuoglio, A. Mai, D. Del Bufalo, 2022, Theranostics.

Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy

F. Sacco, F. Furnari, E. Volpe, 2022, Cell Death & Differentiation.

Bcl-2-like protein-10 increases aggressive features of melanoma cells

I. Manni, A. Filippini, C. Cota, 2022, Exploration of targeted anti-tumor therapy.

Antitumor effect of Melaleuca alternifolia essential oil and its main component terpinen-4-ol in combination with target therapy in melanoma models

D. Del Bufalo, R. Ragno, E. Valentini, 2021, Cell death discovery.

Volatile and Non-Volatile Content Determination and Biological Activity Evaluation of Fresh Humulus lupulus L. (cv. Chinook) Leaves and Inflorescences

M. Iriti, D. Del Bufalo, S. Vitalini, 2023, Separations.

Phytochemicals as Immunomodulatory Agents in Melanoma

F. Facchiano, A. Stringaro, A. Facchiano, 2023, International journal of molecular sciences.

SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma

G. Ciliberto, P. Visca, G. Bossi, 2021, Journal of experimental & clinical cancer research : CR.

Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ

R. Mancini, M. Pisanu, G. Ciliberto, 2017, Oncogene.

Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer

D. Trisciuoglio, D. Del Bufalo, M. Di Martile, 2018, Stem cells international.

The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target

D. Trisciuoglio, D. Del Bufalo, M. Di Martile, 2016, Oncotarget.

microRNA-378a-5p iS a novel positive regulator of melanoma progression

L. Fattore, R. Mancini, G. Ciliberto, 2020, Oncogenesis.

BCL-XL overexpression promotes tumor progression-associated properties

D. Trisciuoglio, D. Del Bufalo, M. Desideri, 2017, Cell Death & Disease.

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma

Nicola Baldini, Michele Milella, D. Trisciuoglio, 2018, Oncogenesis.

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

D. Trisciuoglio, M. Milella, D. Del Bufalo, 2014, Molecular Cancer.

Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance

G. Viglietto, L. Fattore, R. Mancini, 2022, Oncogene.

SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia

D. Del Bufalo, E. Valentini, S. D’Aguanno, 2021, Journal of Experimental & Clinical Cancer Research.

miR‐211 and MITF modulation by Bcl‐2 protein in melanoma cells

V. Farini, D. Trisciuoglio, M. Rizzo, 2016, Molecular carcinogenesis.

Affinity purification-mass spectrometry analysis of bcl-2 interactome identified SLIRP as a novel interacting protein

V. Farini, D. Trisciuoglio, A. Urbani, 2016, Cell Death and Disease.

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

D. Trisciuoglio, M. Milella, D. Del Bufalo, 2014, Molecular Cancer.

BCL-XL overexpression promotes tumor progression-associated properties

D. Trisciuoglio, D. Del Bufalo, M. Desideri, 2017, Cell Death & Disease.

Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment

D. Del Bufalo, S. Buglioni, A. B. Pérez-Oliva, 2023, Journal of Experimental & Clinical Cancer Research.

Bcl-2 family inhibitors sensitize human cancer models to therapy

G. Damia, I. Manni, M. Chiappa, 2023, Cell death & disease.